Encephalopathy following subcutaneous administration of Brixadi® extended-release buprenorphine
Toxicology Reports
· Elsevier
The publisher did not provide an abstract — full text is available via the link below.
Read at publisher →
Citation
Encephalopathy following subcutaneous administration of Brixadi® extended-release buprenorphine. // Toxicology Reports. – URL: https://www.sciencedirect.com/science/article/pii/S2214750026001228?dgcid=rss_sd_all
Encephalopathy following subcutaneous administration of Brixadi® extended-release buprenorphine. Toxicology Reports. https://www.sciencedirect.com/science/article/pii/S2214750026001228?dgcid=rss_sd_all
“Encephalopathy following subcutaneous administration of Brixadi® extended-release buprenorphine.” Toxicology Reports.
@article{article70252,
title = {Encephalopathy following subcutaneous administration of Brixadi® extended-release buprenorphine},
journal = {Toxicology Reports},
url = {https://www.sciencedirect.com/science/article/pii/S2214750026001228?dgcid=rss_sd_all}
}